S. Nagase

10P DS-6000a, a novel CDH6-targeting antibody-drug conjugate with a novel DNA topoisomerase I inhibitor DXd, demonstrates potent antitumor activity in preclinical models

T. Agatsuma, H. Suzuki, T. Nakada, 2021, Annals of Oncology.